Genetically Modified T Cells Treating Malignant Tumors
Clinical trial NCT06515626 · RECRUITING
Trial details
- NCT number
- NCT06515626
- Sponsor
- Yi Zhang
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-18
- Primary completion
- 2025-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.